Antimicrobials | Breakpoint (mg/L) | Number of isolates tested | Number of resistant isolates n (%) | Weighted pooled resistance rate | 95% Confidence interval | Heterogeneity |
---|---|---|---|---|---|---|
Metronidazole | >2 | 5900 | 190 (3.2) | 0.01 | 0–0.03 | 91.97 |
Metronidazole | ≥32 | 13,207 | 129 (1.0) | 0.00 | 0–0.00 | 81.4 |
Vancomycin | ≥32 | 2307 | 13 (0.6) | 0.00 | 0–0.00 | 38.6 |
Vancomycin | ≥16 | 2296 | 10 (0.4) | 0.00 | 0–0.00 | 7.62 |
Vancomycin | ≥4 | 1107 | 7 (0.6) | 0.00 | 0–0.01 | 50.1 |
Vancomycin | >2 | 11,188 | 416 (3.7) | 0.01 | 0–0.02 | 89.79 |
Moxifloxacin | ≥8 | 11,484 | 3912 (34.1) | 0.32 | 0.25–0.4 | 93.89 |
Meropenem | ≥16 | 2756 | 20 (0.7) | 0.00 | 0–0.01 | 71.49 |
Piperacillin/Tazobactam | ≥128/4 | 3041 | 8 (0.3) | 0.00 | 0–0.00 | 0 |
Clindamycin | ≥8 | 19,645 | 6685 (34.0) | 0.59 | 0.53–0.65 | 97.50 |
Ciprofloxacin | ≥8 | 4339 | 3356 (77.0) | 0.95 | 0.85–1.0 | 99.12 |
Tetracycline | ≥16 | 4861 | 886 (18.2) | 0.20 | 0.14–0.27 | 97.04 |
Amoxicillin/Clavulanate | ≥16/8 | 2803 | 4 (0.1) | 0.00 | 0–0.00 | 45.4 |
Ceftriaxone | ≥64 | 3476 | 1289 (37.1) | 0.47 | 0.29–0.65 | 99.05 |
Rifampin | >0.004 | 1861 | 787 (42.3) | 0.37 | 0.18–0.58 | 97.69 |
Moxifloxacin | >4 | 2809 | 929 (33.1) | 0.49 | 0.30–0.67 | 98.68 |
Tigecycline | >0.25 | 2375 | 39 (1.6) | 0.01 | 0–0.03 | 83.53 |